Skip NavigationSkip to Content

Caspase polymorphisms and genetic susceptibility to multiple myeloma

  1. Author:
    Hosgood, H. D.
    Baris, D.
    Zhang, Y.
    Zhu, Y.
    Zheng, T.
    Yeager, M.
    Welch, R.
    Zahm, S.
    Chanock, S.
    Rothman, N.
    Lan, Q.
  2. Author Address

    Hosgood, H. Dean, III, Baris, Dalsu, Zahm, Shelia, Chanock, Stephen, Rothman, Nathaniel, Lan, Qing] NCI, Div Canc Epidemiol & Genet, Occupat & Environm Epidemiol Branch, NIH, Bethesda, MD 20892 USA. [Hosgood, H. Dean, III, Zhang, Yawei, Zhu, Yong, Zheng, Tongzhang] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA. [Yeager, Meredith, Welch, Robert] NCI, SAIC Frederick Inc, Adv Technol Program, Div Canc Epidemiol & Genet,Core Genotyping Facil, Frederick, MD 21701 USA. [Chanock, Stephen] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
    1. Year: 2008
  1. Journal: Hematological Oncology
    1. 26
    2. 3
    3. Pages: 148-151
  2. Type of Article: Article
  1. Abstract:

    Multiple myeloma is a haematological malignency, characterized by clonal expansion of plastma cells. However, little is known about the cause of multiple rnyeloma. Cancer cells must avoid apoptosis to ensure unregulated tumour formation and growth. The highly conserved caspase cascade is essential to the regulation of the apoptotic pathway. To examine if five single nucleotide polymorphisms (SNPs) in four caspase genes [CASP3 Ex8-280 C > A (rs6948), CASP3 Ex8 + 567 T > c (rs1049216), CASP8 Ex14-271 A > T (rs13113). CASP9 Ex5 + 32 G > A (rs1052576), CASPIO Ex3-171 A > G (rs39001150)] alter multiple myeloma risk, we conducted a population-based case-control study of women (128 cases, 516 controls) in Connecticut. Compared to individuals with the TT genotype of CASP3 Ex8 + 567 T > C, subjects with the CC genotype had a five-fold decreased risk of multiple myeloma (odds ratio (OR)(cc) = 0.2, 95% confidence interval (CI)=0.0-1.0). Further, individuals with the AG and AA genotypes of CASP9 Ex5+32 G > A also experienced a decreased risk of multiple myeloma (ORAG=0.8, 95% CI=0.5-1.3, ORAA=0.5, 95% CI=03-0.9, p-trend=0.02). While no previous study has evaluated the association between caspase genes and multiple myeloma, studies have found associations with lung, breast, esophageal, gastric, colorectal and cervical cancers. Our parallel study of non-Hodgkin lymphoma, which utilized the same controls, found strong evidence that caspase genes play a key role in lymphogenesis. The protective associations observed in two key caspase genes suggest that genetic variation in CASP genes may play an important role in the aetiology of multiple myeloma. Copyright (C) 2008 John Wiley & Sons, Ltd.

    See More

External Sources

  1. PMID: 18381704

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel